Answers are grounded in this paper and cite their sources.
Introduction Breast cancer is heterogeneous disease both at clinical and molecular level. Molecular analyses of cancer cells in various stages (subclasses) of progression have revealed that alterations in tumour suppressor genes and oncogenes accumulate during tumour progression and correlate with the clinical aggressiveness of cancer. Tumour
No takes yet. Share an insight, caveat, or question.
Solvang et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: